Nuvectis Pharma Inc
(NVCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,752 | -8,599 | -4,171 | -22,260 | -15,638 |
| Other Working Capital | -747 | -1,337 | -1,483 | 1,601 | 49 |
| Other Operating Activity | 3,717 | 2,558 | 1,296 | 4,705 | 3,485 |
| Operating Cash Flow | $-9,782 | $-7,378 | $-4,358 | $-15,954 | $-12,104 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,083 | 6,576 | 4,849 | 16,481 | 15,580 |
| Other Financing Activity | -258 | -208 | -153 | -1,394 | -1,410 |
| Financing Cash Flow | $7,825 | $6,368 | $4,696 | $15,087 | $14,170 |
| Beginning Cash Position | 19,126 | 19,126 | 19,126 | 19,993 | 19,993 |
| End Cash Position | 17,169 | 18,116 | 19,464 | 19,126 | 22,059 |
| Net Cash Flow | $-1,957 | $-1,010 | $338 | $-867 | $2,066 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,782 | -7,378 | -4,358 | -15,954 | -12,104 |
| Free Cash Flow | -9,782 | -7,378 | -4,358 | -15,954 | -12,104 |